Compounds > calanolide a
Page last updated: 2024-08-24

calanolide a and HIV Coinfection

calanolide a has been researched along with HIV Coinfection in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Han, C; Hu, J; Li, Y; Liu, G; Liu, L; Liu, Z; Lu, X; Ma, T; Wang, L; Xue, H; Zheng, P1
Hanna, L1

Other Studies

3 other study(ies) available for calanolide a and HIV Coinfection

ArticleYear
Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Animals; Anti-HIV Agents; Biological Availability; Brain; Cell Line; Cell Survival; HIV Infections; HIV-1; Inhibitory Concentration 50; Mice; Models, Molecular; Molecular Structure; Mutation; Pyranocoumarins; Rats; Structure-Activity Relationship; Virus Replication

2010
Calanolide looks promising.
    AIDS patient care and STDs, 2000, Volume: 14, Issue:4

    Topics: Anti-HIV Agents; Clinical Trials, Phase II as Topic; Coumarins; Dose-Response Relationship, Drug; HIV Infections; Humans; Malaysia; Prognosis; Pyranocoumarins; Sensitivity and Specificity; Singapore; United States

2000
Calanolide A: a natural non-nucleoside reverse transcriptase inhibitor.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1999, Volume: 12, Issue:2

    Topics: Anti-HIV Agents; Coumarins; HIV Infections; Humans; Multicenter Studies as Topic; Plant Extracts; Pyranocoumarins; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; United States

1999